| CRBP Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the CRBP shares outstanding history going back to 11/12/2014:
Also see: CRBP Market Cap History CRBP YTD Return |
CRBP Shares Outstanding History — Corbus Pharmaceuticals Holdings Share Count Over Time
As of 5/8/2026 Corbus Pharmaceuticals Holdings has 18.53 million CRBP shares outstanding. Investors often track the CRBP shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows CRBP share count trends over time, with 49 historical shares outstanding datapoints presented, dating back to 11/12/2014.
| CRBP Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
CRBP Historical Shares Outstanding: +30.63% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| CRBP Stock Price Chart |
| About Corbus Pharmaceuticals Holdings Inc |
| Corbus Pharmaceuticals Holdings, Inc. is a precision oncology company with a diversified portfolio. Co.'s pipeline is comprised of two experimental drugs targeting solid tumors: CRB-701, which is an antibody drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload and CRB-601, which is an anti-integrin monoclonal antibody that blocks the activation of TGF? expressed on cancer cells. Its pipeline also includes CRB-913, which is a highly peripherally restricted cannabinoid type-1 (CB1) receptor inverse agonist for the treatment of obesity. It has in-licensed the intellectual property for CRB-601 from Dr. We show 49 historical shares outstanding datapoints in our coverage of CRBP's shares outstanding history. Understanding the changing numbers of CRBP shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like CRBP versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching CRBP by allowing them to research CRBP shares outstanding history as well as any other stock in our coverage universe. |
| CRBP Current Stock Quote |
Quotes delayed 20 minutes  Free CRBP Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Shares Outstanding Importance | |
|
Video: Shares Outstanding Importance
| CRBP Share Performance |
| Shares Outstanding Peers |
| Corbus Pharmaceuticals Holdings (CRBP) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
CRBU Shares Outstanding History CRDF Shares Outstanding History CRGX Shares Outstanding History CRH Shares Outstanding History CRIS Shares Outstanding History CRL Shares Outstanding History CRMD Shares Outstanding History CRNX Shares Outstanding History CRTX Shares Outstanding History CRVL Shares Outstanding History More Healthcare companies » |
CRBP Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
